Related papers

How should technical teams evaluate Dunaliella research evidence?

Browse 39 publications across seven research areas, compare the evidence model and trace each record to its original source before applying it to an ingredient or formulation decision.

  • 39 papers
  • 7 research areas
  • Evidence-type filters
7human studies

Clinical or human-sample research

20animal-model papers

Preclinical in vivo evidence

10cell or tissue papers

Mechanistic and ex vivo work

2mixed-model papers

More than one preclinical model

Library definition

What is the Dunaliella paper library?

The Dunaliella paper library is a source index classified by research topic and evidence model. It contains 39 papers across 7 research areas; every record retains its title, authors, journal, year, study model, summary and original source link. The library supports evidence discovery and reading, but it does not imply that every paper used a HETCHYN or Carovive® ingredient.

Current scope
39 papers · 7 research areas
Evidence models
Human · animal · cell or tissue · mixed preclinical
Review owner
Research review by HETCHYN Scientific & Technical Team

Static topic index

Which research areas does the library cover?

This topic index remains readable before scripts load; the interactive library below adds evidence-type and keyword filters.

018

Vision & retinal science

Human and preclinical work on retinal function, retinoid-cycle disorders and 9-cis beta-carotene.

028

Cardiovascular health

Cholesterol transport, macrophage biology, atherosclerosis models and human lipid observations.

034

Metabolic health

Glucose regulation, adipose inflammation, LDL oxidation and high-fat-diet models.

043

Neurodegenerative research

Cell and animal studies examining cognition, neuroinflammation and neuronal stress.

054

Oxidative stress & healthy ageing

Antioxidant, mitochondrial, lifespan and radiation-exposure research across several models.

065

Oncology research

Early-stage cell and animal research on Dunaliella extracts across selected tumour models.

077

Inflammation, liver & skin

Human and preclinical work spanning psoriasis, inflammation, liver injury and skin ageing.

Evidence composition

How should technical teams compare the 39 Dunaliella research records?

The library covers publications from 1998 to 2024. Compare each record by study model before using it for ingredient review, formulation planning or scientific discussion.

Evidence modelRecordsWhat it can supportWhat it cannot establish alone
Human study7Findings for the studied population, material, dose and designAutomatic applicability to another ingredient, dose or finished product
Animal model20Preclinical responses, mechanisms and directions for later researchHuman efficacy or a finished-product health claim
Cell or tissue model10Mechanistic observations under controlled in vitro or ex vivo conditionsA clinical outcome, consumer benefit or commercial-product claim
Mixed preclinical2Evidence observed across more than one preclinical modelClinical substantiation without relevant human research
Use boundary

Counts describe the current 39-paper bibliography. Inclusion means the source is relevant to Dunaliella, natural beta-carotene or 9-cis beta-carotene; it does not mean the study used a HETCHYN or Carovive® ingredient.

Evidence reading flow

How to evaluate a Dunaliella research record in four steps.

This reading order prevents a preclinical mechanism, a published human finding and a registered protocol from being treated as equivalent evidence.

Browse classified papers
  1. 01
    Step 1 · Evidence model

    Identify who or what was studied

    Start by classifying the record as a human study, animal model, cell or tissue model, or mixed preclinical study.

  2. 02
    Step 2 · Material

    Confirm the species and test material

    Check whether the study used a Dunaliella species, whole algae, an extract, a carotenoid fraction or a defined beta-carotene isomer profile.

  3. 03
    Step 3 · Study design

    Read dose, comparator and endpoints

    Review the population or model, dose, duration, comparator and measured endpoints before interpreting the reported outcome.

  4. 04
    Step 4 · Claim boundary

    Separate the finding from the product claim

    Limit the conclusion to the studied material and design, then verify any HETCHYN role or finished-product claim through its own source.

Paper library

Search by research area or study model.

Each paper is labelled by the model it actually used. Cell and animal findings remain preclinical, and inclusion does not mean the study used a HETCHYN product.

Loading the paper library…

How to read this library

Related science is context, not a finished-product claim.

These papers study different species, strains, extracts, doses and experimental models. They support scientific review and research planning. They do not establish that every result applies to a HETCHYN ingredient or to a customer’s finished product.

Paper library FAQ

What should readers know before using the library?

These answers define the library's scope, classification method and use boundaries.

01How many papers and research areas are in the library?

The current library contains 39 papers across 7 research areas. Records are classified as human, animal, cell or tissue, or mixed preclinical evidence.

02Does inclusion mean a paper studied Carovive®?

No. A record is included because it is relevant to Dunaliella, natural beta-carotene or 9-cis beta-carotene. A HETCHYN or Carovive® relationship is stated only when an approved source establishes it.

03How should I compare human and preclinical evidence?

Read the study model first. Human findings are limited to the studied population and material; animal and cell studies can guide mechanisms but cannot be restated as human efficacy.

04Are negative or non-supportive findings included?

Yes. The library is designed for evidence review rather than promotional selection, so a study remains eligible when its design and source are relevant even if the reported outcome is negative.

05Can HETCHYN provide a focused paper set?

Yes. Provide the research question, evidence model, target market and intended ingredient or dosage form so the technical team can organize a relevant source set.

Scope39-paper bibliography, evidence composition, authors and source links
Verification sourcesDOI records · Crossref · PubMed · CNKI record

Talk to our ingredient team

Need a paper set for a specific research area?

Tell us the application, evidence question and market. Our technical team can assemble the most relevant references alongside the appropriate ingredient documentation.

Request a research pack